Free Trial

Genus (LON:GNS) Reaches New 12-Month High - What's Next?

Genus logo with Medical background

Key Points

  • Genus plc's stock reached a new 52-week high of GBX 2,555 ($33.97) during trading, closing at GBX 2,506.57 ($33.33) with a trading volume of 847 shares.
  • Analysts have issued a "buy" rating for Genus, with Shore Capital setting a price target of GBX 2,750 ($36.56) and Deutsche Bank raising their target to GBX 2,550 ($33.91).
  • The company operates in animal genetics with a market cap of £1.65 billion and offers products through its three segments: Genus PIC, Genus ABS, and Genus Research and Development.
  • Need Better Tools to Track Genus? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Genus plc (LON:GNS - Get Free Report)'s stock price reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 2,555 ($34.36) and last traded at GBX 2,506.57 ($33.71), with a volume of 847 shares trading hands. The stock had previously closed at GBX 2,495 ($33.55).

Analyst Upgrades and Downgrades

GNS has been the topic of several recent research reports. Shore Capital reissued a "buy" rating and issued a GBX 2,750 ($36.98) price target on shares of Genus in a report on Tuesday, July 15th. Deutsche Bank Aktiengesellschaft increased their target price on Genus from GBX 2,250 ($30.26) to GBX 2,550 ($34.29) and gave the stock a "buy" rating in a research report on Tuesday, July 15th.

Get Our Latest Report on Genus

Genus Trading Up 0.4%

The firm's 50-day simple moving average is GBX 2,184.09 and its 200 day simple moving average is GBX 1,968.12. The stock has a market cap of £1.64 billion, a P/E ratio of 207.64, a PEG ratio of 2.87 and a beta of 0.37. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

See Also

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines